Danaher Corporation (DHR) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.
Total Assets Chart for Danaher Corporation
Danaher Corporation (DHR) total assets for FY2025 were USD 83.5B, a 7.6% change from FY2024. Danaher Corporation's total assets grew from USD 268.9M in 1985 to USD 83.5B in 2025 (30939.0% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 1.8%, 10-year CAGR of 5.6%, 20-year CAGR of 11.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $140.58B
- Implied Share Price
- $199.98
- Enterprise Value
- $159.28B
- Revenue (TTM)
- $25.11B
- EBITDA
- $8.03B
- Profit Margin
- 15.95%
- Trailing P/E
- 35.65
- Forward P/E
- 22.88
- Price/Book (MRQ)
- 2.61
- Price/Sales (TTM)
- 5.60
- EV/EBITDA
- 21.00
- EV/Revenue
- 6.34
- Dividend Yield
- 0.72%
- Book Value
- $74.81
- Free Cash Flow (FY2025)
- $5.26B
- Free Cash Flow Yield
- 3.74%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.